BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

First published online December 10, 2007
British Journal of Radiology (2008) 81, 107-112
© 2008 British Institute of Radiology
doi: 10.1259/bjr/944470077

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YOSHIMATSU, R
Right arrow Articles by NISHIMURA, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YOSHIMATSU, R
Right arrow Articles by NISHIMURA, T

Full paper

Percutaneous needle biopsy of lung nodules under CT fluoroscopic guidance with use of the "I-I device"

R YOSHIMATSU, MD T YAMAGAMI, MD, PhD 1 T KATO, MD, PhD 1 T HIROTA, MD 1 T MATSUMOTO, MD 1 J SHIMADA, MD, PhD 2 and T NISHIMURA, MD, PhD 1

Departments of 1 Radiology and 2 General Thoracic Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-chyo, Kawaramachi-Hirokoji, Kamigyo, Kyoto, 602-8566, Japan

Correspondence: Rika Yoshimatsu, MD, Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-chyo, Kawaramachi-Hirokoji, Kamigyo, Kyoto, 602-8566, Japan. E-mail: rika442{at}koto.kpu-m.ac.jp

The aim of this study is to evaluate the feasibility and safety of CT fluoroscopic-guided needle biopsy with the use of the "I-I device", which was developed to assist in precisely advancing the needle while avoiding irradiation to the operator's hand. Using the "I-I device" under CT fluoroscopic guidance, 131 percutaneous needle lung biopsies were performed followed by histopathological evaluation. The final diagnosis was confirmed by independent surgical pathological findings or clinical follow-up. The rate of success in obtaining specimens adequate for histopathological analysis was 100% (131/131). For the 104 lesions that we were able to follow up, sensitivity, specificity and accuracy in diagnosing malignancy were 93.8%, 100% and 95.2%, respectively. In 51 lesions for which surgery was performed, the specific cell type was characterized in 98.0% (50/51; malignant, n = 38; benign, n = 12). The specific cell type was precisely diagnosed and confirmed after surgery in 36 malignant lesions and 8 benign lesions. Biopsy-induced complications were pneumothorax in 34.0% (44/131) and haemoptysis in 9.9% (13/131). None of the patients had serious complications. In conclusion, CT fluoroscopic-guided lung biopsy with use of the "I-I device" provides a high degree of diagnostic accuracy, allows specific characterization of lung nodules and can be performed safely.




This article has been cited by other articles:


Home page
Radiat Prot DosimetryHome page
C. J. Martin
A REVIEW OF RADIOLOGY STAFF DOSES AND DOSE MONITORING REQUIREMENTS
Radiat Prot Dosimetry, September 16, 2009; (2009) ncp168v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2008 by the British Institute of Radiology.